NYS Department of Health Announces Launch of Medical Marijuana Program

In July 2014, Governor Andrew M. Cuomo and the New York State Legislature enacted the Compassionate Care Act to provide a comprehensive, safe and effective medical marijuana program that meets the needs of New Yorkers.  The law currently identifies use of medical marijuana for certified patients with the following serious conditions:

  1. Cancer

  2. Positive status for HIV or AIDS

  3. Amyotrophic Lateral Sclerosis (ALS) Lou Gehrig’s disease

  4. Parkinson’s disease

  5. Huntington’s disease

  6. Multiple Sclerosis

  7. Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity

  8. Epilepsy

  9. Inflammatory Bowel Disease

  10. Neuropathies

  11. Chronic pain lasting more than 3 months, with failed use or contraindication of other medications. (effective 3/22/2017)

PLUS diagnosed with any of the following symptoms where it is clinically associated with a complication or its treatment: Cachexia or wasting syndrome, severe or chronic pain, severe nausea, seizures, severe or persistent muscle spasms or such conditions as added by the Commissioner.

Crain’s Business NY talks to Dr. Huang (6/20/16)

National Academies of Sciences Cannabis Health Effects report (Jan 2017)

Medical Marijuana – Drug Policy Alliance (June 2016)

Please call (917) 364-4885 to make an appointment for an initial patient evaluation.    


logo_MCC_color (1)Manhattan Compassionate Care (MCC) is the first medical practice in Manhattan qualified to accept patients for the NY State Medical Marijuana Program.  MCC is a trusted authority with a fully comprehensive clinical approach from initial evaluation until the date of certification. The Manhattan Compassionate Care Pathway was developed by Dr. Dara Huang, M.D., a Board Certified Physician in Internal Medicine with a subspecialty in Nephrology. Dr. Huang was certified to become a Compassionate Care New York Physician by the New York Department of Health after successfully completing the state-mandated Practitioner Education for the Medical Marijuana Program on the use of pharmaceutical cannabis, its biochemical properties, and therapeutic dosing. Initial consultation may not guarantee certification, as evidence of the underlying medical condition and indications for symptomatic treatment must be demonstrated. Risks, benefits and alternatives will be evaluated for compassionate drug use. Upon completion, patients will also be assisted with the process of obtaining a legal medical card from the New York State Department of Health as part of services provided by Manhattan Compassionate Care.

For more information, please visit:

American Cancer Society

National Cancer Institute

New York State Medical Marijuana Program


PRE-VISIT REQUIREMENTS

  • Must be a legal resident of New York State with proof of residency i.e. state identification card, driver’s license. Non-New York State residents receiving care and treatment in this state may qualify for registration as a certified patient if the applicant is temporarily residing in New York State for the purpose of receiving care and treatment from a practitioner registered with the department.

  • Must be at least the age of 18.

  • Patients must have a documented medical record of diagnosis and course of treatment for a serious condition for eligibility for medical cannabis. Alternatively, you can give your physician this sample letter to complete, indicating your qualifying condition and associated symptom. Sample letter of qualifying condition

  • The NY Dept of Health requires a bona fide relationship between the patient and certifying physician, as such before the physician can recommend a patient for the use of medical cannabis to ensure a safe therapeutic approach. Upon completion, the patient will be issued the certifying practitioner’s recommendation as required by the NYS Dept of Health to obtain the NYS Medical Marijuana card.   

    Please call (917) 364-4885 to make an appointment for an initial patient evaluation.